Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

Cited by (402)

Items 301–400 of 402

1. Immune Checkpoint Inhibitors Serve as the First‐Line Treatment for Advanced Head and Neck Cancer
   Yan Huang, Hong Zhou, Guangyong Zhao, Meihua Wang, Judong Luo, Jun Liu · 2023 · The Laryngoscope
2. Regulation of DNA damage-induced HLA class I presentation
   Yuki Uchihara, Atsushi Shibata · 2023 · DNA repair
3. Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases
   Johnny Kao, Michelle Sahagian, Vani Gupta, Symeon Missios, Ashish Sangal · 2023 · Frontiers in Oncology
4. Abscopal effect in maxillary sinus cancer: Insights from two case reports and a literature review
   Akihiro Sakai, Koji Ebisumoto, Hiroaki Iijima, Mayu Yamauchi, Daisuke Maki, Tsuyoshi Fukuzawa, Kenji Okami · 2024 · Cancer Reports
5. Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy
   Rachel Radigan, Ashish Sangal, Dong Zhang, Jonathan Weber, Megha Schmalzle, Alexa Finkelstein, Vaibhav Duggal, Johnny Kao · 2025 · PLoS ONE
6. Patterns of care in de-novo oligo-metastatic and oligo-recurrent head and neck cancers: A Head and Neck Cancer International Group (HNCIG) Survey.
   Monali Swain, Sarbani Ghosh Laskar, Lachlan J. McDowell, Christina E. Henson, Pierluigi Bonomo, Sadhana Kannan, Timothy Dean Malouff, Akihiro Homma, Alexander Rühle, Anna Lee et al. · 2025 · Oral Oncology
7. A tolerability and safety analysis of adding granulocyte-macrophage colony-stimulating factor to local radiotherapy in a case series of seven patients with thoracic cancer
   Bi‐Cheng Wang, Pengcheng Li, Bo‐Hua Kuang, Zhanjie Zhang, Bo‐Ya Xiao, Guo‐He Lin, Quentin Liu · 2021 · Annals of Palliative Medicine
8. A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
   Re-I Chin, Joshua P. Schiff, Randall Brenneman, Hiram Alberto Gay, Wade L. Thorstad, Alexander J. Lin · 2021 · Cancers
9. Systemischer Effekt einer lokalen Strahlentherapie: erste klinische Evidenz
   Matthias Gückenberger · 2021 · Strahlentherapie und Onkologie
10. Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers: The Early Experience of Two Academic Center
    Camil Ciprian Mireștean, Mihai Cosmin Stan, Michael Schenker, Constantin D. Volovat, Simona Ruxandra Volovăț, Dragoş Petru Teodor Iancu, Roxana Irina Iancu, Florinel Bădulescu · 2023 · Preprints.org
11. Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease
    Connor M. Lynch, Muzamil Arshad, Rohan Reddy Katipally, Sean P. Pitroda, Ralph R. Weichselbaum · 2024 · Journal of Clinical Oncology
12. Radiotherapy and blockade of immune checkpoints in treatment of cancer patients
    I. А. Hromakova, П.П. Сорочан, V.P. Starenkyі, N. E. Prokhach, I. S. Hromakova · 2023 · Український радіологічний та онкологічний журнал
13. The Future of Radiosurgery and SBRT: SRS and SBRT Complications and Management
    Praveen Pendyala, John H. Suh, Simon Shek-Man Lo, Erin Sennett Murphy, Ehsan H. Balagamwala, Samuel T. Chao · 2024 · Springer eBooks
14. The Proimmunomodulatory and Anti-immunomodulatory Effects of Radiotherapy in Oncologic Care
    Bryan Johnson, Qianyu Guo, Keyur Chaludiya, Sungjune Kim · 2025 · Hematology/Oncology Clinics of North America
15. Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial
    Marco Carlo Merlano, Nerina Denaro, Matteo Paccagnella, Andrea Abbona, Danilo Galizia, Salvatore Alfieri, Cristiana Bergamini, Ester M. Orlandi, Anna Maria Merlotti, Stefano Bondi et al. · 2025 · ESMO Open
16. SIRPα + CD209 + cell: a specialized antigen-presenting cell that contributes to anti-SIRPα/RT therapy in colorectal cancer
    Yida Li, Weiqing Lu, Fan Xia, Yun Deng, Xin Jin, Yan Xuan, Yaqi Wang, Lijun Shen, Juefeng Wan, Hui Zhang et al. · 2025 · Cancer Immunology Immunotherapy
17. Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911
    Corey Jay Langer, Jonathan Harris, Eric Mark Horwitz, Merrill S. Kies, Voichita Bar Ad, Stuart J. Wong, Jimmy J. Caudell, Kenneth Lee Zeitzer, Sharon A. Spencer, Qiang Zhang et al. · 2025 · International Journal of Radiation Oncology*Biology*Physics
18. Roles of the phagocytosis checkpoint in radiotherapy
    Yulan Kui, Fan Tong, Ruiguang Zhang, Jian Wang, Xiaorong Dong · 2025 · Cell Death and Disease
19. Towards a personalized utilization of stereotactic body radiotherapy for the management of liver metastases in solid tumors
    Pierre-Antoine Laurent, Kanta Ka, Matthieu Roulleaux Dugage, A. Levy, R. Bahleda, J. Durand-Labrunie, C. Massard, Eric Deutsch, Roger Sun · 2025 · Cancer Metastasis Review
20. Abscopal Effect Induced by LAG-3/PD-1 Inhibition and Radiation Therapy in Metastatic Acral Melanoma: A Case Report
    Stanley Kim, William Stull, Dan Ishihara, Frank Sabatelli, Joseph I. Clark · 2025 · Case Reports in Oncology
21. Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial
    Jonathan So, Alexander D. Droznin, Payal Tiwari, Yu-Hui Chen, Nicole Grace Chau, Danielle Nina Margalit, Roy B. Tishler, Glenn J. Hanna, Raymond H. Mak, Kelly J. Fitzgerald et al. · 2026 · International Journal of Radiation Oncology*Biology*Physics
22. The emerging role of neoadjuvant immunotherapy in locally advanced oral squamous cell carcinoma: progress and challenges
    Tongchao Zhao, Yi-Bin Dai, Zhi-Hang Zhou, Ying-Ying Huang, Lai‐ping Zhong · 2026 · International Journal of Surgery
23. Multicenter real-world data on immunotherapy for R/M HNSCC from China: comprehensive analysis of efficacy and survival differences across diverse clinical backgrounds, and identification of predictive peripheral blood biomarkers
    Feifan Sun, Shasha Pu, Bing-Xin Hou, J Liu, Changhao Liu, Jian Zang, Haichuan Su, Zhongwei Wang, Xuejiao Song, Siyu Wang et al. · 2026 · Frontiers in Immunology
24. Pharmacovigilance Assessment of PD-1 Antibody Therapy in Head and Neck Cancer: Risk Factor Analysis Using FAERS Database
    Qian Gao, Linli Xie, Yu Qin, Jiangchuan Xie · 2026 · Clinical Therapeutics
25. Complete locoregional response to radiotherapy and pembrolizumab in an elderly and frail patient with oropharyngeal squamous cell carcinoma: A case report
    Flaminia Benedetta Zoboli, Mirta Mosca, Ambrogio Gagliano, Viola Laghi, GIAMBATTISTA SIEPE, Karim Rihawi, Elisabetta Nobili, Daria Maria Filippini · 2026 · Medicine
26. Stereotactic body radiotherapy combined with immunotherapy: a systematic review focus on timing and toxicity profile
    Carlo Guglielmo Cattaneo, Giuditta Chiloiro, Angela Romano, Giulia Panza, Matteo Galetto, Matteo Nardini, Lorenzo Placidi, Maria Antonietta Gambacorta, Luca Boldrini · 2026 · Technical Innovations & Patient Support in Radiation Oncology
27. Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming
    Laiyan Zhou, Yuanxin Liu, Zherui Xing, Yuanjun Wu, Xue YANG, Siyuan Chen, Kai Kang, Min Wang, Zhipeng Zhou, Meijuan Huang et al. · 2026 · Signal Transduction and Targeted Therapy
28. Could the association of sunitinib and stereotactic ablative radiotherapy lead to abscopal effect in metastatic renal cell carcinoma?
    Chiara Lucrezia Deantoni, Simone Baroni, Silvia Foti, Andrei Fodor, Gianluca Del Conte, N.G. Di Muzio · 2022 · Journal of Clinical Images and Medical Case Reports
29. Translational and Clinical Approach to Combining Immunotherapy with Radiotherapy in the Treatment of Head and Neck Cancer
    Quaovi H. Sodji, Dhanya K. Nambiar, Quynh‐Thu Le · 2022 · Cancer immunotherapy
30. Contribution of chemotherapy in immunoradiotherapy combinations
    Y. Xie, Benoît Lecoester, Jihane Boustani · 2023 · Cancer/Radiothérapie
31. Stereotactic Radiotherapy in Combination with Immunotherapy in Treatment of Advanced Recurrent Squamous Cell Carcinoma of the Larynx
    Paweł Polanowski, Aleksandra Nasiek, Aleksandra Grządziel, Agnieszka Pietruszka, Krzysztof Składowski, Katarzyna Polanowska · 2023 · Biomedicines
32. A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma
    Jeremy Phillip Harris, Jino Park, Eric Ku, Steven Neema Seyedin, Russell N. Stitzlein, Amanda Goldin, Wen‐Pin Chen, Christine E. McLaren, Allen M. Chen, Warren Allen Chow · 2024 · Cancer Control
33. Extra-cranial radiotherapy in anti-PD-1-treated melanoma patients: A systematic review
    Philippe Saïag, Lucien Lahmi, Elisa Funck‐Brentano · 2024 · EJC Skin Cancer
34. Neoadjuvant immunotherapy and oncolytic virotherapy in HPV positive and HPV negative skin cancer: A comprehensive review
    Ali Salimi Asl, Mohsen Davari, Atousa Ghorbani, Narjes Seddighi, Kimia Arabi, Ehsan Saburi · 2024 · International Immunopharmacology
35. Principles of specific treatment and palliative care in advanced head and neck cancer
    Roxana-Andreea Rahnea-Niță, Radu-Valeriu Toma, Valentin Titus Grigorean, Anghel Rodica Maricela, Laura Florentina Rebegea, Nadejda Corobcean, Alexandru-Rares Stoian, Anda-Natalia Ciuhu, Cristinel Dumitru Badiu · 2024 · Romanian Journal of Oral Rehabilitation
36. A bibliometric analysis of immune response in oral cancer
    Rongrong Zhang, Runying Guo, Yuqi Xin, Qingkun Jiang, Jiaxuan Qiu · 2025 · Discover Oncology
37. Radiotherapy and immunotherapy combination in head and neck cancer: Does current failure qualify as an ending or is it a key to future success?
    Panagiota Economopoulou, Ioannis Kotsantis, Amanda K. Psyrri · 2022 · Oral Oncology
38. Rethinking Radiation Dose-Fractionation in the Immuno- Oncology Era
    Joseph Sia, Nicole M. Haynes · 2021 · Journal of Cellular Immunology
39. Durable complete response rates following radiotherapy and immunotherapy combination in recurrent and metastatic head and neck squamous cell carcinoma: A retrospective single‐centre cohort study
    Raj Khera, Laura Feeney, Martin Swinton, Samuel Rack, Andrew J. Sykes, Robert Lewin Metcalf · 2022 · Clinical Otolaryngology
40. Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report
    Mihaela D. Aldea, Rakiba Belkhir, Émeline Colomba, Pierre Blanchard, François‐Xavier Danlos, Angela Botticella, Mario Terlizzi, Éric Deutsch, Cecile Le Pechoux, David Planchard et al. · 2022 · Frontiers in Immunology
41. Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
    Mathieu Spaas, Nora Sundahl, Piet Ost · 2021 · European Urology
42. Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
    Markus Tobias Grabbert, Anca‐Ligia Grosu, Constantinos Zamboglou, Christian Gratzke · 2022 · European Urology
43. In regard to Cabezas-Camarero et al.
    Melek Tuğçe Yılmaz, Sezin Yüce Sarı, Gözde Yazıcı · 2023 · Anti-Cancer Drugs
44. Durvalumab, Tremelimumab Alone or in Combination With Low-Dose or Hypofractionated Targeted Radiotherapy in Metastatic Non-Small Cell Lung Cancer Refractory to Prior PD-1 Therapy: A Multicentre, Open-Label, Randomized, Phase 2 Trial
    Jonathan Daniel Schoenfeld, Anita Giobbie‐Hurder, Srin Ranasinghe, Katrina Z. Kao, Ana Lako, Junko Tsuji, Yang Liu, Ryan C. Brennick, Ryan D. Gentzler, Carrie B. Lee et al. · 2021 · SSRN Electronic Journal
45. THE ROLE OF STEREOTAXIC BODY RADIOTHERAPY (SBRT) IN THE TREATMENT OF PATIENTS WITH DISTANT METASTASES
    Natalia Dengina · 2021 · Practical oncology
46. Lecture abstracts
    2021 · Liječnički vjesnik
47. Particle Therapy and the Immune System
    Sherif G. Shaaban, Daniel K. Ebner, Osama Mohamad · 2022 · Wiley eBooks
48. Radiotherapy and Immunotherapy for Head and Neck Cancer
    Jack M. Qian, Jonathan Daniel Schoenfeld · 2022 · Springer eBooks
49. Radiation-Induced Immunoediting of Cancer
    Slavisa Tubin, R. Horsman Michael, S. Sørensen Brita, Seema Gupta, M. M. Khan · 2023 · Springer eBooks
50. Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis from Head and Neck Cancer: The Potential Survival Benefits from PD-1 Inhibitors
    Hua Ye, Nan Liu, Jin T, Jin Q, Hu Q, Dong R · 2022 · Austin Journal of Cancer and Clinical Research
51. Radio-Chemo-Therapie
    Victor Lewitzki, Michael P. Flentje · 2022 · Springer eBooks
52. Immune Checkpoint Inhibition and Radiotherapy in Head and Neck Squamous Cell Carcinoma: Synergisms and Resistance Mechanisms
    Nikko Brix, Kirsten Lauber · 2023 · Springer eBooks
53. Data from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
    Thomas E. Bickett, Michael W. Knitz, Laurel B. Darragh, Shilpa Bhatia, Benjamin Van Court, Jacob Gadwa, Shiv Bhuvane, Miles Piper, Diemmy Nguyen, Hua Tu et al. · 2023
54. Data from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
    Thomas E. Bickett, Michael W. Knitz, Laurel B. Darragh, Shilpa Bhatia, Benjamin Van Court, Jacob Gadwa, Shiv Bhuvane, Miles Piper, Diemmy Nguyen, Hua Tu et al. · 2023
55. Palliative radiotherapy in oligometastases
    Matthew N. Mills, Anupam Rishi, Daniel Eli Oliver, Hsiang-Hsuan Michael Yu · 2023 · Elsevier eBooks
56. The Interplay Between Radiation Dose, Volume, and Systemic Therapy
    David J Thomson, Christina E. Henson, Shao Hui Huang, Lachlan J. McDowell, Michelle Lynn Mierzwa, Christopher T. Wilke, Danielle Nina Margalit · 2023 · International Journal of Radiation Oncology*Biology*Physics
57. Head and Neck
    Christina Phuong, Jason Wei Siang Chan · 2023 · Springer eBooks
58. Immunotherapy in oral cancer: Review
    Despoina Papaioannou, Spyridoula Petsali, Alida Ndreou, Fani Akritidou, Vasileios Zisis, Dimitrios Kavvadas, Athanasios K. Poulopoulos, Sofia Karachrysafi, Dimitrios Andreadis · 2023 · Balkan Journal of Dental Medicine
59. Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy
    Xin Shan, Paul A. Renauer, Chuanpeng Dong, Yanzhi Feng, Ping Ren, Qianqian Lin, Feifei Zhang, Narges Tafreshi, Peter M. Glazer, Sidi Chen et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
60. Radiotherapy in the management of lung oligometastases
    Vincent Bourbonne, Antonin Lévy, Jonathan Khalifa, D. Antoni, E. Blais, J. Darréon, Cecile Le Pechoux, D. Lerouge, Philippe Giraud, Alexis Marguerit et al. · 2024 · Cancer/Radiothérapie
61. Treatment of recurrent and/or metastatic disease
    M. Plana Serrahima, Ricard Mesı́a · 2024 · Revisiones en cáncer
62. Role of radiotherapy and re-irradiation in recurrence and metastatic disease
    Fernando Puebla Díaz, R Rodríguez · 2024 · Revisiones en cáncer
63. RETRACTED CHAPTER: Lymphoma Vaccines: Background and Perspectives
    Thomas Wölfel · 2024 · Cancer immunotherapy · Retracted
64. Radiation and Immunotherapy in Breast Cancer
    Anthony Tuan Nguyen, Stephen Lawrence Shiao, Heather L. McArthur · 2024 · Cancer immunotherapy
65. Immunotherapy
    2024 · Elsevier eBooks
66. Immunomodulation induced by FLASH radiotherapy
    Aymeric Almeida, Marie‐Catherine Vozenin · 2024 · Elsevier eBooks
67. Impact of radiotherapy on peripheral T lymphocytes in hypopharyngeal squamous cell carcinoma
    Hanqing Lin, Yu Heng, Xiaoke Zhu, Tian Wang, Lei Tao · 2024 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
68. Stereotactic Body Radiation Therapy (SBRT) for Lung Metastases
    Christopher Williamson, William A. Stokes · 2024 · Springer eBooks
69. CD8 + T cells in patients with hypopharyngeal squamous cell carcinoma are susceptible to radiation‐induced damage
    Hanqing Lin, Jingyu Ma, Yu Heng, Xiaoke Zhu, Qiu-yan Jin, Xuping Ding, Lei Tao, Liming Lu · 2025 · International Journal of Cancer
70. Non-targeted effects of stereotactic radiotherapy: a review of the evidence coming from the clinical field
    Angela Barillaro, Mara Caroprese, Chiara Feoli, Emanuele Chioccola, Christina Amanda Goodyear, Caterina Oliviero, Stefania Clemente, Antonio Farella, Manuel Conson, Roberto Pacelli · 2025 · Exploration of Targeted Anti-tumor Therapy
71. Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?
    Sean Matthew McBride · 2025 · International Journal of Radiation Oncology*Biology*Physics
72. Combination of External Beam Radiation Therapy and Immune Checkpoint Inhibitors in Cancer Treatment: Mechanisms, Limitations, and Clinical Applications
    Anusha Muralidhar, Malick Bio Idrissou, Quaovi H. Sodji · 2025 · Applied Radiation Oncology
73. Dual PD ‐1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers
    Cristina P. Rodriguez, Qian Vicky Wu, Kevin Ng, Jenna M. Voutsinas, Jonathan R. Fromm, Ariana Dumenigo‐Jimenez, Renato G Martins, Keith D. Eaton, Rafael Santana-Dávila, Christina S. Baik et al. · 2025 · Head & Neck
74. Global Perspectives and Future Directions in Head and Neck Cancer
    Zodwa Dlamini, Talent Chipiti, Solly Selahle, Rodney Hull, Demetra Demetriou, Georgios Lolas · 2025
75. Oligometastatic head and neck cancer: Navigating patient trajectories and broader implications
    Juliette Thariat, Jihane Lehyanti, Pierre Boisselier, A. Modesto, S. Thureau, Y. Pointreau, Xu-Shan Sun · 2025 · Cancer/Radiothérapie
76. Promising Targets and Drugs for Improving Head and Neck Cancer Response to Radiotherapy
    Faris Anad Muhammad, Ayat Hussein Adhab, Morug Salih Mahdi, Ashishkumar Kyada, Subbulakshmi Ganesan, Deepak Bhanot, Kandi Satyam Naidu, Aseel Salah Mansoor, Usama Kadem Radi, Nasr Saadoun Abd et al. · 2025 · Current Pharmaceutical Design
77. Radiation-Induced Immunoediting of Cancer
    Slavisa Tubin, R. Horsman Michael, S. Sørensen Brita, Seema Gupta, M. M. Khan · 2025 · Springer eBooks
78. Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group
    Constance Golfier, A Visy, Anna Gueiderikh, Johann Marcel, Alexandre Escande, Julien Scala‐Bertola, Maude Metzger, Aurélien Lambert, J.-C. Faivre · 2025 · Cancer and Metastasis Reviews
79. Toxicities of Overlapping Spine Radiotherapy and Systemic Therapy
    J. Haseltine · 2025 · Springer eBooks
80. Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery
    Troy J. Kleber, Denái R. Milton, Subasree Srinivasan, Bikash Panthi, Warren N. Floyd, Eric A. Goethe, Michael A. Davies, Hussein A. Tawbi, Isabella C. Glitza Oliva, Diana Kaya et al. · 2026 · Neuro-Oncology Advances
81. Bacteria outer membrane-based oxygen gels alleviate tumor hypoxia for enhanced systemic immune response to radiotherapy
    Deyuan Zheng, Junhong Yao, Haiheng Xu, Shuqin Xiong, Qingsong Ye, Y. Chen, Chuan Zhao, Min Zhang, Xuehui Rui, Jinhui Wu · 2026 · Science China Materials
82. Management of head and neck squamous cell carcinoma in combination with pulmonary embolism: An adverse event of combined anti–PD-1 and EGFR neoadjuvant immunotherapy
    Yuan Zhi, Ling Gao, Wenhao Ren, Keqian Zhi · 2026 · Asian Journal of Surgery
83. Case Report: Discordant pancreatic inflammatory pseudotumor in a breast cancer survivor – a diagnostic dilemma
    Zhe Cao, Xiaohong Lyu, Xin Lü, Taiping Zhang · 2026 · Frontiers in Oncology
84. Clinical-oriented strategies in intraperitoneal therapy: Drug delivery systems for precision treatment of peritoneal metastases
    Liangwei Si, Zixuan Wang, Xiaoling Lu, Yingqi Lu, Yan Li, Zhao Wang, Fei Xiong · 2026 · Journal of Drug Delivery Science and Technology
85. A new perspective on radiotherapy in the comprehensive treatment of cancer
    Yingze Ma, Hongxuan Yu, Shijie Shang, Shixin Shan, Dawei Chen · 2026 · Precision Radiation Oncology
86. Clinical efficacy of anti-PD-1 immunotherapy with localized non-ablative irradiation against metastatic lymph node in patients with metastatic gastric cancer
    Kosaku Mimura, Yoshiyuki Suzuki, Shotaro Nakajima, Takashi Ogata, Michael Fehlings, Katsuharu Saito, Yuya Yoshimoto, Daisaku Yoshida, Nozomu Machida, Takanobu Yamada et al. · 2026 · Clinical and Translational Radiation Oncology
87. Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer
    Ryan T. Hughes, Sydney Smith, Thomas William Lycan, Paul M. Bunch, Ralph B. D’Agostino, Bart A. Frizzell, Rebecca D Kinney, Shafaq Rashid, Pierre Triozzi, W Zhang et al. · 2026 · JAMA Otolaryngology–Head & Neck Surgery
88. In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models
    Trishna Debnath, Won Jong Jin, Ravi B. Patel, Peter M. Carlson, Md. Mahfuzur Rahman, Tracy J. Berg, Caroline P. Kerr, Rene Welch, Yujuan Wang, Meredith Hyun et al. · 2026 · Cancer Immunology Research
89. Integration of immunotherapy with radiotherapy in head-and-neck cancer: Synergy or sequencing?
    Venkata Pradeep Babu Koyyala, Anindya Mukherjee · 2026 · International Journal of Molecular and Immuno Oncology
90. Differential impact of lymphocytes on radiation response in autochthonous vs transplant murine sarcomas
    Yvonne Marie Mowery, Aastha Sobti, Alex M. Bassil, Amy J. Wisdom, Collin L. Kent, Chang Su, Jonathon Himes, Eric S. Xu, Nerissa T. Williams, Lixia Luo et al. · 2026 · JNCI Journal of the National Cancer Institute
91. Irradiation-based development of tumor vaccines: Mechanistic insights and translational exploration
    Jiangwen Tian, Xianglong Feng, Boyi Yu, Jiahao Zhang, Jinyue Jing, Xiaodong Jin · 2026 · Critical Reviews in Oncology/Hematology
92. Microenvironment-defined priority pathways shape ICD-driven abscopal responses
    Xiaobo Sun, Dandan Guo, Zhenrong Wang, Peixin Sun · 2026 · Frontiers in Immunology
93. Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances
    Yihong Dong, Moran Chen, Xupeng Hou, Xiaoya Tang, Xiaoli Yu, Jing Liu · 2026 · MedComm
94. Beyond the tumor microenvironment: a hierarchical immune-circuit model of immune checkpoint blockade resistance
    Xue Zhao, Han Wang, Yanan Liu, Lanqing Cao · 2026 · Frontiers in Oncology
95. Acral versus Cutaneous Melanoma: Distinct Biology and the Emerging Immunomodulatory Role of Radiotherapy
    Stanley Kim, Joseph I. Clark, William C. Small · 2026 · Advances in Radiation Oncology
96. From DNA damage to systemic immunity: Interaction networks in radio-immunotherapy
    Ruixue Huang · 2026 · Cell Insight
97. Beyond local control: radiotherapy–immunotherapy combinations from in situ vaccination to systemic immune remodeling
    Yulong Wen, Nannan Cheng, Sheng Zhou, Haixia Zhu, Qin Ge · 2026 · Frontiers in Genetics
98. Ultrahigh-Dose-Rate Radiation Therapy Spares Lymphocytes and Increases T cell Infiltration in Human Papillomavirus–Positive Tumors
    Francisco Sáenz, Brett Velasquez, Trey Waldrop, Edgardo A Aguilar, Kathryn R. Cox, Abagail M. Delahoussaye, Caddie Laberiano-Fernández, Letícia Campos Clemente, Luke Connell, Nefetiti Mims et al. · 2026 · Advances in Radiation Oncology
99. Advances in Hypofractionated Radiotherapy Combined with Immune Checkpoint Inhibitors for Head and Neck Cancer
    彦晨 公 · 2026 · Advances in Clinical Medicine
100. Risk factors and treatment outcomes of metachronous isolated distant metastasis in oral squamous cell carcinoma: A multicenter retrospective cohort study in Japan
     Yasumasa Kakei, Takumi Hasegawa, Takumi Imai, Hiroshi Nakamura, Nobuhiro Yamakawa, Yusuke Yokota, Masaya Okura, Tomofumi Naruse, Hiroshi Kurita, Eiji Hirai et al. · 2026 · Oral Oncology Reports